Posts

COVID-19 Pandemic Study of Ketamine Amplifies Antidepressant Potential

COVID-19 Pandemic Study of Ketamine Therapy Amplifies Antidepressant Potential

,
Study authors even believe "treating serious mental illness may reduce adverse outcomes related to COVID-19."
Big Pharma Giant Merck Partners With Psychedelic Research Company NovaMind

Big Pharma Giant Merck Partners With Psychedelic Research Company Novamind

Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.